Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer.
Takeshi SasakiKouhei NishikawaManabu KatoSatoru MasuiYuko YoshioYoshiki SugimuraTakahiro InouePublished in: Medical sciences (Basel, Switzerland) (2021)
Although our study included a small number of cases, at least in our exploration, NCHT was safe and feasible. However, more extensive treatment modalities are needed to improve outcomes, especially in VHR patients.
Keyphrases
- radical prostatectomy
- prostate cancer
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- squamous cell carcinoma
- locally advanced
- radiation therapy
- adipose tissue
- type diabetes
- patient reported outcomes
- mesenchymal stem cells
- metabolic syndrome
- combination therapy
- weight loss
- patient reported